United States
US 12,702,662 B2
Use of pridopidine and analogs for treating Rett syndrome
US 12,702,662 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-11. Applicant: PRILENIA NEUROTHERAPEUTICS LTD. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- PRILENIA NEUROTHERAPEUTICS LTD.
- Inventors
- Michael HAYDEN; Michal GEVA
- Publication date
- 2026-08-11
- Filing date
- 2023-05-17
- Document type
- B2 Granted patent
- Also written as
- US 12,702,662 B2 · US12702662 · 12702662
Abstract
The subject invention provides a method for treating a subject afflicted with Rett syndrome comprising administering to the subject a pharmaceutical composition comprising pridopidine or pharmaceutical acceptable salts and at least one of compounds 1-8 or pharmaceutical acceptable salt thereof disclosed herein, so as to thereby treat the subject.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free